» Articles » PMID: 21881869

Four-year Results Following Treatment of Intrabony Periodontal Defects with an Enamel Matrix Derivative Alone or Combined with a Biphasic Calcium Phosphate

Overview
Specialty Dentistry
Date 2011 Sep 2
PMID 21881869
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to evaluate the 4-year clinical outcomes following regenerative surgery in intrabony defects with either EMD + BCP or EMD. Twenty-four patients with advanced chronic periodontitis, displaying one-, two-, or three-walled intrabony defect with a probing depth of at least 6 mm, were randomly treated with either EMD + BCP (test) or EMD alone (control). The following clinical parameters were evaluated at baseline, at 1 year and at 4 years after regenerative surgery: plaque index, gingival index, bleeding on probing, probing depth, gingival recession, and clinical attachment level (CAL). The primary outcome variable was CAL. No differences in any of the investigated parameters were observed at baseline between the two groups. The test group demonstrated a mean CAL change from from 10.8 ± 1.6 mm to 7.4 ± 1.6 mm (p < 0.001) and to 7.6 ± 1.7 mm (p < 0.001) at 1 and 4 years, respectively. In the control group, mean CAL changed from 10.4 ± 1.3 at baseline to 6.9 ± 1.0 mm (p < 0.001) at 1 year and 7.2 ± 1.2 mm (p < 0.001) at 4 years. At 4 years, two defects in the test group and three defects in the control group have lost 1 mm of the CAL gained at 1 year. Compared to baseline, at 4 years, a CAL gain of ≥3 mm was measured in 67% of the defects (i.e., in 8 out of 12) in the test group and in 75% of the defects (i.e., in 9 out of 12) in the control group. There were no statistically significant differences in any of the investigated parameters at 1 and at 4 years between the two groups. Within their limits, the present results indicate that: (a) the clinical improvements obtained with both treatments can be maintained over a period of 4 years, and (b) in two- and three-walled intrabony defects, the addition of BCP did not additionally improve the outcomes obtained with EMD alone. In two- and three-walled intrabony defects, the combination of EMD + BCP did not show any advantage over the use of EMD alone.

Citing Articles

Enamel matrix derivative monotherapy versus combination therapy with bone grafts for periodontal intrabony defects: An updated review.

Hasuike A, Watanabe T, Hirooka A, Arai S, Akutagawa H, Yoshinuma N Jpn Dent Sci Rev. 2024; 60:239-249.

PMID: 39507278 PMC: 11539096. DOI: 10.1016/j.jdsr.2024.08.001.


Periodontal Regenerative Therapy Using rhFGF-2 and Deproteinized Bovine Bone Mineral versus rhFGF-2 Alone: 4-Year Extended Follow-Up of a Randomized Controlled Trial.

Seshima F, Bizenjima T, Aoki H, Imamura K, Kita D, Irokawa D Biomolecules. 2022; 12(11).

PMID: 36421696 PMC: 9688011. DOI: 10.3390/biom12111682.


Regenerative potential of biphasic calcium phosphate and enamel matrix derivatives in the treatment of isolated interproximal intrabony defects: a randomized controlled trial.

Pal P, Bali A, Boyapati R, Show S, Tejaswi K, Khandelwal S J Yeungnam Med Sci. 2022; 39(4):322-331.

PMID: 36050839 PMC: 9580055. DOI: 10.12701/jyms.2022.00325.


The granulation tissue preservation technique in regenerative periodontal surgery-a randomized controlled clinical trial.

Adam K, Gunay H, Vaske B, Flohr M, Staufenbiel I Clin Exp Dent Res. 2022; 8(1):9-19.

PMID: 35018724 PMC: 8874108. DOI: 10.1002/cre2.532.


Combination of enamel matrix derivative and hyaluronic acid inhibits lipopolysaccharide-induced inflammatory response on human epithelial and bone cells.

Ramenzoni L, Annasohn L, Miron R, Attin T, Schmidlin P Clin Oral Investig. 2021; 26(2):1773-1783.

PMID: 34460002 PMC: 8816768. DOI: 10.1007/s00784-021-04152-8.


References
1.
Heijl L . Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol. 1997; 24(9 Pt 2):693-6. DOI: 10.1034/j.1600-051x.1997.00693.x. View

2.
Loe H . The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol. 1967; 38(6):Suppl:610-6. DOI: 10.1902/jop.1967.38.6.610. View

3.
Gunsolley J, Elswick R, Davenport J . Equivalence and superiority testing in regeneration clinical trials. J Periodontol. 1998; 69(5):521-7. DOI: 10.1902/jop.1998.69.5.521. View

4.
Scheyer E, Mellonig J . Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol. 2002; 73(4):433-40. DOI: 10.1902/jop.2002.73.4.433. View

5.
Hammarstrom L, Heijl L, Gestrelius S . Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol. 1997; 24(9 Pt 2):669-77. DOI: 10.1111/j.1600-051x.1997.tb00248.x. View